Standardized Extract of Atractylodis Rhizoma Alba and Fructus Schisandrae Ameliorates Coughing and Increases Expectoration of Phlegm.
Hee-Sung ChaeSun Young KimPisey PelJungmoo HuhSun-Woo JooYun Young LimShin Jung ParkJong Lae LimYoung-Won ChinPublished in: Molecules (Basel, Switzerland) (2020)
Cough and phlegm frequently occur in respiratory diseases like upper respiratory tract infections, acute bronchitis, and chronic obstructive pulmonary diseases. To relieve these symptoms and diseases, various ingredients are being used despite the debates on their clinical efficacy. We aimed to investigate the effects of the extract CKD-497, composed of Atractylodis Rhizoma Alba and Fructus Schisandrae, in relieving cough and facilitating expectoration of phlegm. CKD-497 was found to inhibit inflammatory mediators such as interleukin-8 (IL-8) and tumor necrosis factor α (TNF-α) in lipopolysaccharide (LPS)-treated mouse macrophages and transient receptor potential cation channel 1 (TRPV-1)-overexpressed human bronchial epithelial cells stimulated by capsaicin. CKD-497 decreased the viscosity of the mucin solution. During in vivo experiments, CKD-497 reduced coughing numbers and increased expectoration of phlegm via mucociliary clearance enhancement. Collectively, these data suggest that CKD-497 possesses potential for cough and phlegm expectoration treatment.
Keyphrases
- chronic kidney disease
- respiratory tract
- oxidative stress
- rheumatoid arthritis
- endothelial cells
- inflammatory response
- pulmonary hypertension
- human health
- drug induced
- mouse model
- toll like receptor
- binding protein
- machine learning
- blood brain barrier
- replacement therapy
- aortic dissection
- acute respiratory distress syndrome
- sleep quality
- climate change
- physical activity
- brain injury
- cerebral ischemia
- lps induced